Preclinical Services Overview
State-of-the-art methods for accelerating your drug development.
Preclinical support to ultimately cure patients
Founded in 2012, InnoSer is an innovative and dynamic contract research organization (CRO) supporting the preclinical development of drugs. Our mission is to accelerate drug development by offering well-characterized and translational research models and innovative CRO services.
Our Focus
From target validation to preclinical stages of the development pipeline
InnoSer actively guides and supports our customers with a variety of in vivo and in vitro methods backed by niche expertise and therapeutic knowledge.
Our Pillars
Quality in vitro and in vivo services to fit your project
Drug Development Services
Pharmacology and efficacy studies
- PK/PD studies
- Optimal dose determination studies
- Non-GLP toxicology
- Biocompatibiltiy studies
- 2D/3D cell culture
- Organoids
- High content imaging
- Live cell imaging
- Bioluminescence imaging
- Ultrasound
- Confocal microscopy
- Digital histopathology
- Biomarker analysis
- Flow cytometry
Facility management
- Contract breeding
- Cryopreservation and rederivation
- Cardiac surgery
- Stereotactic injection
- Implantation of tumors
- Medical device testing
- Disease model development
- Vaccine development
Therapeutic Expertise
Rare Disease
- Polycystic Kidney Disease
- Stxbp1 encephalopathy
- Fragile X syndrome
- Amyotrophic lateral sclerosis
- Duchenne Muscular Dystrophy
- Vanishing white matter
- In vitro cell lines & PDO bank
- In vivo CDX & PDX models
- Orthotopic & syngeneic models
- Humanized IC & IS models
- Broad Immuno-oncology readouts
- In vitro & in vivo (behavioral) models
- Central & peripheral system
- Neurodegenerative diseases
- Psychiatric conditions
- Ageing
- Ischemic heart disease
- Hypertrophic heart disease
- Diabetes type I & II
- Liver inflammation & fibrosis
- NASH/NAFLD